JP2004502640A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502640A5 JP2004502640A5 JP2001557366A JP2001557366A JP2004502640A5 JP 2004502640 A5 JP2004502640 A5 JP 2004502640A5 JP 2001557366 A JP2001557366 A JP 2001557366A JP 2001557366 A JP2001557366 A JP 2001557366A JP 2004502640 A5 JP2004502640 A5 JP 2004502640A5
- Authority
- JP
- Japan
- Prior art keywords
- adenosine
- fibrosis
- administering
- subject
- need
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010016654 Fibrosis Diseases 0.000 claims 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 6
- 208000004930 Fatty Liver Diseases 0.000 claims 4
- 206010019708 Hepatic steatosis Diseases 0.000 claims 4
- 230000007882 cirrhosis Effects 0.000 claims 4
- 208000019425 cirrhosis of liver Diseases 0.000 claims 4
- 208000010706 fatty liver disease Diseases 0.000 claims 4
- 230000004761 fibrosis Effects 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 3
- 229960005305 adenosine Drugs 0.000 claims 3
- 239000002467 adenosine A2a receptor antagonist Substances 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000000638 stimulation Effects 0.000 claims 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18154600P | 2000-02-10 | 2000-02-10 | |
| PCT/US2001/004341 WO2001058241A2 (en) | 2000-02-10 | 2001-02-12 | Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004502640A JP2004502640A (ja) | 2004-01-29 |
| JP2004502640A5 true JP2004502640A5 (OSRAM) | 2005-02-03 |
Family
ID=22664744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001557366A Pending JP2004502640A (ja) | 2000-02-10 | 2001-02-12 | 肝繊維症、硬変症および脂肪肝を治療および予防するアデノシンａ２ａ受容体拮抗薬 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6555545B2 (OSRAM) |
| EP (1) | EP1272897B1 (OSRAM) |
| JP (1) | JP2004502640A (OSRAM) |
| AT (1) | ATE394104T1 (OSRAM) |
| AU (2) | AU2001238124B2 (OSRAM) |
| CA (1) | CA2398908C (OSRAM) |
| DE (1) | DE60133887D1 (OSRAM) |
| DK (1) | DK1272897T3 (OSRAM) |
| ES (1) | ES2307593T3 (OSRAM) |
| PT (1) | PT1272897E (OSRAM) |
| WO (1) | WO2001058241A2 (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6196459B1 (en) * | 1998-05-11 | 2001-03-06 | Ubiq Incorporated | Smart card personalization in a multistation environment |
| WO2003080649A2 (en) * | 2002-03-20 | 2003-10-02 | Regents Of The University Of Minnesota | Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| ITRM20070088A1 (it) * | 2007-02-19 | 2008-08-20 | Francesco Fringuelli | Composti derivati della colchicina, procedimento per la loro preparazione e usi in campo medico. |
| WO2009023179A2 (en) * | 2007-08-10 | 2009-02-19 | Genelabs Technologies, Inc. | Nitrogen containing bicyclic chemical entities for treating viral infections |
| EP2217233B1 (en) * | 2007-10-26 | 2018-08-08 | New York University School of Medicine | Methods and compositions for treating hepatic diseases |
| KR101516677B1 (ko) * | 2008-01-31 | 2015-05-04 | 고토부키 세이야쿠 가부시키가이샤 | 지방성 간 질환의 치료용 의약 조성물 |
| US8536306B2 (en) | 2008-10-01 | 2013-09-17 | The Scripps Research Institute | Human A2A adenosine receptor crystals and uses thereof |
| US20100204265A1 (en) * | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
| BRPI1009398A2 (pt) | 2009-03-13 | 2016-03-08 | Advinus Therapeutics Private Ltd | compostos de pirimidina fundida substituída |
| WO2010106145A1 (en) * | 2009-03-20 | 2010-09-23 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Oxidated derivatives of triazolypurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| US8796290B2 (en) | 2009-11-09 | 2014-08-05 | Advinus Therapeutics Limited | Substituted fused pyrimidine compounds, its preparation and uses thereof |
| SG183146A1 (en) | 2010-02-05 | 2012-09-27 | Heptares Therapeutics Ltd | 1,2,4-triazine-4-amine derivatives |
| WO2012066330A1 (en) | 2010-11-17 | 2012-05-24 | Heptares Therapeutics Limited | Compounds useful as a2a receptor inhibitors |
| CN110809577A (zh) | 2017-06-30 | 2020-02-18 | 雷沃医疗有限公司 | 腺苷a2a受体的调节剂 |
| CA3086282A1 (en) | 2017-12-19 | 2019-06-27 | Impetis Biosciences Ltd. | Pharmaceutical composition for the treatment of cancer |
| EP3735413B1 (en) | 2018-01-04 | 2022-07-06 | Impetis Biosciences Ltd. | Tricyclic compounds, compositions and medicinal applications thereof |
| WO2020128036A1 (en) | 2018-12-21 | 2020-06-25 | Ryvu Therapeutics S.A. | Modulators of the adenosine a2a receptor |
| WO2025018901A1 (en) | 2023-07-17 | 2025-01-23 | Ryvu Therapeutics S.A. | Modulators of the adenosine a2a and a2b receptor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4705658A (en) | 1986-04-07 | 1987-11-10 | Capsule Technology International, Ltd. | Method for drying gelatin in the manufacture of hard shell gelatin capsules |
| US5063233A (en) | 1986-11-14 | 1991-11-05 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists |
| US4968697A (en) | 1987-02-04 | 1990-11-06 | Ciba-Geigy Corporation | 2-substituted adenosine 5'-carboxamides as antihypertensive agents |
| US5036381A (en) | 1990-06-15 | 1991-07-30 | Motorola, Inc. | Multiple electronic devices within a single carrier structure |
| GB2264948B (en) | 1992-03-13 | 1996-10-16 | Merck & Co Inc | Human adenosine receptors |
| US5426101A (en) | 1992-09-30 | 1995-06-20 | Merrell Dow Pharmaceuticals Inc. | 2-substituted adenosines with A-2 receptor affinity |
| AU6516494A (en) | 1993-04-15 | 1994-11-08 | New York University | Adenosine receptor agonists for the promotion of wound healing |
| US5877180A (en) * | 1994-07-11 | 1999-03-02 | University Of Virginia Patent Foundation | Method for treating inflammatory diseases with A2a adenosine receptor agonists |
| US5859019A (en) | 1997-03-07 | 1999-01-12 | Trustees Of The University Of Pennsylvania | Methods for protecting against cardiac ischemia by administering adenosine A2a receptor antagonists |
| AU750322B2 (en) | 1997-05-09 | 2002-07-18 | Trustees Of The University Of Pennsylvania, The | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
| AU7449598A (en) * | 1997-05-23 | 1998-12-11 | Nippon Shinyaku Co. Ltd. | Medicinal composition for prevention or treatment of hepatopathy |
| US5916910A (en) | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
| US6303619B1 (en) * | 1998-03-12 | 2001-10-16 | University Of Virginia | Meta-substituted acidic 8-phenylxanthine antagonists of A3 human adenosine receptors |
| US6232297B1 (en) * | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
-
2001
- 2001-02-12 US US09/780,365 patent/US6555545B2/en not_active Expired - Lifetime
- 2001-02-12 WO PCT/US2001/004341 patent/WO2001058241A2/en not_active Ceased
- 2001-02-12 EP EP01910529A patent/EP1272897B1/en not_active Expired - Lifetime
- 2001-02-12 AU AU2001238124A patent/AU2001238124B2/en not_active Ceased
- 2001-02-12 ES ES01910529T patent/ES2307593T3/es not_active Expired - Lifetime
- 2001-02-12 CA CA002398908A patent/CA2398908C/en not_active Expired - Fee Related
- 2001-02-12 AU AU3812401A patent/AU3812401A/xx active Pending
- 2001-02-12 PT PT01910529T patent/PT1272897E/pt unknown
- 2001-02-12 DK DK01910529T patent/DK1272897T3/da active
- 2001-02-12 JP JP2001557366A patent/JP2004502640A/ja active Pending
- 2001-02-12 DE DE60133887T patent/DE60133887D1/de not_active Expired - Lifetime
- 2001-02-12 AT AT01910529T patent/ATE394104T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004502640A5 (OSRAM) | ||
| WO2005027895A3 (en) | Thyroid hormone analogs and methods of use in angiogenesis | |
| TW200731968A (en) | Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist | |
| JP2004515500A5 (OSRAM) | ||
| WO2003037271A3 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| ATE431738T1 (de) | Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist | |
| FR2798747B1 (fr) | Composition de photoreserve contenant un generateur de photobase avec generateur de photo-acide | |
| BR0311843A (pt) | Métodos para prevenir, inibir, tratar ou reduzir esteatose hepática não- alcoólica em um animal e para prevenir o desenvolvimento e/ou a reversão do processo de nafld em um animal | |
| JP2008532951A5 (OSRAM) | ||
| MA29600B1 (fr) | Utilisation de sanglifehrine dans le virus de l'hepatite c | |
| JP2005516719A5 (OSRAM) | ||
| JP2004504320A5 (OSRAM) | ||
| DK1272897T3 (da) | Adenosin-A2A-receptorantagonister til behandling og forebyggelse af leverfibrose, cirrose og fedtlever | |
| EP1575571A4 (en) | COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF A TUMOR | |
| ATE285469T1 (de) | Zusammensetzung zum reinigen von harten oberflächen | |
| WO2007034188A3 (en) | Chemo-immunotherapy method | |
| DE60231386D1 (de) | Adenosin-a2a-rezeptor-antagonisten in kombination mit verbindungen mit neurotrophischer aktivität bei der behandlung von morbus parkinson | |
| CA2378613A1 (en) | Selective iglur5 receptor antagonists for the treatment of migraine | |
| DE60208190D1 (de) | Verkapselte konzentrate zum reinigen von harten oberflächen | |
| EP1470240A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES USING 1682, 6169, 6193, 7771, 14395, 29002, 33216, 43726, 69292, 21656, 32427, 2402, 7747, 1720, 9151, 60491, 1371, 7077, 33207, 1419 , 18036, 16105, 38650, 14245, 58848, 1870, 25856, 32394, 3484, 345, 9252, 9135, 10532, 18610, 8165, 2 | |
| EP3078386A3 (en) | Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor | |
| ITMI20001631A0 (it) | Procedimento per la rimozioni di metalli pesanti, in particolare dell'arsenico, dall'acqua ed apparecchiatura per la sua esecuzione. | |
| EP1583966A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING GENES 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33 | |
| EP1550442A4 (en) | COMPOSITION FOR PREVENTION / TREATMENT OF THE IMPACT OF CLINICAL SYMPTOMS IN DISEASES EMBODIED BY MITOCHONDRIENE DYSFUNCTION | |
| EP1613369A4 (en) | COMPOSITIONS AND METHODS OF DELIVERING THYMOSINE BETA 4, ANALOGUE, ISOFORMS AND OTHER DERIVATIVES |